A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to Cetuximab

NCT01338558 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: bevacizumab [Avastin]
DRUG: cetuximab
DRUG: mFOLFOX6

Sponsor

Hoffmann-La Roche